The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 21,151 | 1,300,000 | SH | OTR | 1,300,000 | 0 | 0 | ||
| BEIGENE LTD | SPONSORED ADR | 07725L102 | 108,499 | 630,000 | SH | OTR | 630,000 | 0 | 0 | ||
| BELLEROPHON THERAPEUTICS INC | COM | 078771102 | 1,601 | 1,482,143 | SH | OTR | 1,482,143 | 0 | 0 | ||
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 23,202 | 2,094,000 | SH | OTR | 2,094,000 | 0 | 0 | ||
| DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 33,690 | 1,500,000 | SH | OTR | 1,500,000 | 0 | 0 | ||
| ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 61,009 | 1,375,000 | SH | OTR | 1,375,000 | 0 | 0 | ||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 4,422 | 200,000 | SH | OTR | 200,000 | 0 | 0 | ||
| KINIKSA PHARMACEUTICALS LTD | COM CL A | G5269C101 | 29,904 | 1,172,700 | SH | OTR | 1,172,700 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 14,784 | 844,789 | SH | OTR | 844,789 | 0 | 0 | ||
| MEDICINES CO | COM | 584688105 | 41,874 | 1,400,000 | SH | OTR | 1,400,000 | 0 | 0 | ||
| MEI PHARMA INC | COM NEW | 55279B202 | 12,555 | 2,913,091 | SH | OTR | 2,913,091 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 73,738 | 1,565,560 | SH | OTR | 1,565,560 | 0 | 0 | ||
| NOVUS THERAPEUTICS INC | COM | 67011N105 | 1,515 | 324,383 | SH | OTR | 324,383 | 0 | 0 | ||
| ODONATE THERAPEUTICS INC | COM | 676079106 | 54,871 | 2,826,938 | SH | OTR | 2,826,938 | 0 | 0 | ||
| PTC THERAPEUTICS INC | COM | 69366J200 | 101,285 | 2,155,000 | SH | OTR | 2,155,000 | 0 | 0 | ||
| REATA PHARMACEUTICALS INC | CL A | 75615P103 | 32,704 | 400,000 | SH | OTR | 400,000 | 0 | 0 | ||
| REGULUS THERAPEUTICS INC | COM | 75915K101 | 4,026 | 1,697,802 | SH | OTR | 1,697,802 | 0 | 0 | ||
| RIGEL PHARMACEUTICALS INC | COM NEW | 766559603 | 7,453 | 2,321,900 | SH | OTR | 2,321,900 | 0 | 0 | ||
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 48,404 | 1,966,051 | SH | OTR | 1,966,051 | 0 | 0 | ||
| SOLID BIOSCIENCES INC | COM | 83422E105 | 135,954 | 2,881,600 | SH | OTR | 2,881,600 | 0 | 0 | ||
| SUNESIS PHARMACEUTICALS INC | COM PAR | 867328700 | 4,250 | 2,125,000 | SH | OTR | 2,125,000 | 0 | 0 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 808 | 100,000 | SH | OTR | 100,000 | 0 | 0 | ||
| WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 79,530 | 1,590,600 | SH | OTR | 1,590,600 | 0 | 0 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 3,960 | 300,000 | SH | OTR | 300,000 | 0 | 0 | ||